Even a pandemic can’t slow down Seattle Genetics’ new bladder cancer treatment Padcev, which “blew out sales expectations” […]
Researchers in virology and veterinary bacteriology at the University of Bern have cloned the novel coronavirus (SARS-CoV-2). The […]
The covid-19 pandemic has brought into sharp focus the need for care planning, especially with our older and […]
The higher covid-19 mortality rate among people from black and minority ethnic (BME) backgrounds—both in healthcare workers and […]
GPs will be required to give extra support to care homes, including a weekly review of patients, within […]
In this article by Ho and colleagues (BMJ 2020;368, doi:10.1136/bmj.m688, published 18 March 2020) the data for two […]
What is happening to non-covid deaths?In this feature by John Appleby (BMJ 2020;369:m1607, doi:10.1136/bmj.m1607) figure 2 used weekly […]
The move will establish Menarini’s presence in the US biopharma market
The experimental 5-HT1A receptor agonist and D2 receptor antagonist was not effective on primary or secondary endpoints
BCC marks the second non-melanoma skin cancer for which Libtayo has demonstrated first-in-class data, the firms note